NCT00576784View on ClinicalTrials.gov

Metabolic Effects of Pioglitazone in Type II Diabetic Patients Previously Treated With Insulin

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

April 30, 2005

Study Completion Date

April 30, 2007

Conditions
Type 2 Diabetes MellitusInsulin Resistance
Interventions
DRUG

pioglitazone and glimepiride

switch from any insulin treatment to 30 mg pioglitazone and 3 mg glimepiride.

Trial Locations (1)

55116

IKFE, Mainz

All Listed Sponsors
lead

IKFE Institute for Clinical Research and Development

OTHER

NCT00576784 - Metabolic Effects of Pioglitazone in Type II Diabetic Patients Previously Treated With Insulin | Biotech Hunter | Biotech Hunter